Skip to main content

Advertisement

Log in

Occurrence of bacterial and toxic metals contamination in illegal opioid-like drugs in Iran: a significant health challenge in drug abusers

  • Short Communication
  • Published:
DARU Journal of Pharmaceutical Sciences Aims and scope Submit manuscript

Abstract

Background

The toxic metals and/or bacterial contaminants in illicit drugs are the main health problems in drug users worldwide. Hence, the potential risks of these contaminants were evaluated in some of the illicit drugs during 2015 and 2016.

Methods

The metals analysis were performed using graphite furnace atomic absorption spectrophotometry. In addition, all microbiological analysis stages, including handling procedures, dilution, and culture media, were conducted in accordance with the US Pharmacopeia (USP) which are harmonized with the European Pharmacopoeia (EP).

Results

In the present study, the highest lead (Pb; 138.10 ± 75.01 μg/g) and chromium (Cr; 447.38 ± 20.27 μg/g) levels were detected in opium samples. In addition, the highest prevalence of microbial contamination was observed in opium samples, and the lowest was recorded in heroin samples. Clostridium tetani, with about 50% of contaminant, was the most common bacteria in the analyzed samples.

Conclusions

Our results indicate that Pb exposure as well as bacterial contamination could be the major threats for drug users.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Martínez MA, Ballesteros S, Almarza E, Garijo J. Death in a legal poppy field in Spain. Forensic Sci Int. 2016;265:34–40.

    Article  PubMed  Google Scholar 

  2. Karbakhsh M, Salehian Zandi N. Acute opiate overdose in Tehran: the forgotten role of opium. Addict Behav. 2007;32(9):1835–42.

    Article  PubMed  Google Scholar 

  3. Zaaijer ER, Bruijel J, Blanken P, Hendriks V, Koeter MWJ, Kreek MJ, et al. Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence. Drug Alcohol Depend. 2014;145:101–5.

    Article  PubMed  Google Scholar 

  4. Van Nuijs AL, Castiglioni S, Tarcomnicu I, et al. Illicit drug consumption estimations derived from wastewater analysis: a critical review. Sci Total Environ. 2011;409(19):3564–77.

    Article  CAS  PubMed  Google Scholar 

  5. Rosen L, Katzman K. Afghanistan: Drug Trafficking and the 2014 Transition Washington: The Congressional Research Service, 2014. Available from: http://goodtimesweb.org/overseas-war/2014/R43540.pdf

  6. Oskarsson K. The role of Iran in Afghanistan’s reconstruction & development. Civil-military fusion center, August, 2013.

  7. Kazemifar AM, Solhi H, Badakhshan D. Crack in Iran: is it really cocaine. J Addict Res Ther. 2011;2(1):1–3.

    Google Scholar 

  8. Karrari P, Mehrpour O, Balali-Mood M. Iranian crystal: a misunderstanding of the crystal-meth. J Res Med Sci. 2012;17(2):203–4.

    PubMed  PubMed Central  Google Scholar 

  9. Fallahzadeh MA, Salehi A, Naghshvarian M, Fallahzadeh MH, Poustchi H, Sepanlou SG, et al. Epidemiologic study of opium use in pars cohort study: a study of 9000 adults in a rural southern area of Iran. Arch Iran Med. 2017;20(4):205–10.

    PubMed  Google Scholar 

  10. Menati W, Valizadeh R, Menati R, Niazi M, Nazarzadeh M, Bidel Z. Determination of opium abuse prevalence in Iranian young people: a systematic review and meta-analysis. J Subst Use. 2017;22(1):3–10.

    Article  Google Scholar 

  11. Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal. 2011;3(2):89–96.

    Article  CAS  PubMed  Google Scholar 

  12. Shesser R, Jotte R, Olshaker J. The contribution of impurities to the acute morbidity of illegal drug use. Am J Emerg Med. 1991;9(4):336–42.

    Article  CAS  PubMed  Google Scholar 

  13. Schneider S, Meys F. Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005–2010. Forensic Sci Int. 2011;212(1):242–6.

    Article  CAS  PubMed  Google Scholar 

  14. Tchounwou PB, Yedjou CG, Patlolla AK, et al. Heavy metal toxicity and the environment, in Molecular, clinical and environmental toxicology Springer 2012; 133–64.

  15. Ghaderi A, Vahdati-Mashhadian N, Oghabian Z, et al. Thallium exists in opioid poisoned patients. Daru. 2015;23(1):1–4.

    Article  CAS  Google Scholar 

  16. Aghaee-Afshar M, Khazaeli P, Behnam B, Rezazadehkermani M, Ashraf-Ganjooei N. Presence of lead in opium. Arch Iran Med. 2008;11(5):553–4.

    CAS  PubMed  Google Scholar 

  17. Khatibi-Moghadam H, Khadem-Rezaiyan M, Afshari R. Comparison of serum and urine lead levels in opium addicts with healthy control group. Hum Exp Toxicol. 2016;5:861–5.

    Article  CAS  Google Scholar 

  18. Karrari P, Mehrpour O, Abdollahi M. A systematic review on status of lead pollution and toxicity in Iran; guidance for preventive measures. Daru. 2012;20(1):2–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ghaemi K, Ghoreishi A, Rabiee N, et al. Blood lead levels in asymptomatic opium addict patients; a case control study. Emerg. 2017;5(1):e69.

    Google Scholar 

  20. Lavender TW, McCarron B. Acute infections in intravenous drug users. Clin Med. 2013;13(5):511–3.

    Article  Google Scholar 

  21. Brett MM, Hood J, Brazier JS, et al. Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom. Epidemiol Infect. 2005;133(4):575–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Farjo P, Jain A, Patel K. Bacterial endocarditis in an intravenous drug user with a ventricular septal aneurysm. W V med J. OA, 2017.

  23. Andrade AP, Pacheco SD, Silva FQ, et al. Characterization of hepatitis B virus infection in illicit drug users in the Marajó archipelago, northern Brazil. Arch Virol. 2017;162(1):227–33.

    Article  CAS  PubMed  Google Scholar 

  24. Page K, Morris MD, Hahn JA, Maher L, Prins M. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis. 2013;57(suppl_2):S32–8.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Jain V, Yang MH, Kovacicova-Lezcano G, et al. Infective endocarditis in an urban medical center: association of individual drugs with valvular involvement. J Inf Secur. 2008;57(2):132–8.

    Google Scholar 

  26. Saydain G, Singh J, Dalal B, Yoo W, Levine DP. Outcome of patients with injection drug use–associated endocarditis admitted to an intensive care unit. J Crit Care. 2010;25(2):248–53.

    Article  PubMed  Google Scholar 

  27. Marín-Navarrete R, Magis-Rodríguez C, Strathdee SA. Sexually transmitted infections and substance use disorders: evidence and challenges in Mexico. Salud Ment. 2017;40(1):1–4.

    Article  Google Scholar 

  28. Domeneh BH, Tavakoli N, Jafari N. Blood lead level in opium dependents and its association with anemia: a cross-sectional study from the capital of Iran. J Res Med Sci. 2014;19(10):939–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Russell L, Pedersen M, Jensen AV, Søes LM, Hansen ABE. Two anthrax cases with soft tissue infection, severe oedema and sepsis in Danish heroin users. BMC Infect Dis. 2013;13(1):408.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Heshmati A, Karami-Momtaz J, Nili-Ahmadabadi A, Ghadimi S. Dietary exposure to toxic and essential trace elements by consumption of wild and farmed carp (Cyprinus carpio) and Caspian kutum (Rutilus frisii kutum) in Iran. Chemosphere. 2017;173:207–15.

    Article  CAS  PubMed  Google Scholar 

  31. Hanif H, Anjum A, Ali N, et al. Isolation and antibiogram of clostridium tetani from clinically diagnosed tetanus patients. Am J Trop Med Hyg. 2015;93(4):752–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Masoodi M, Zali MR, Ehsani-Ardakani MJ, Mohammad-Alizadeh AH, Aiassofi K, Aghazadeh R, et al. Abdominal pain due to lead-contaminated opium: a new source of inorganic lead poisoning in Iran. Arch Iran Med. 2006;9(1):72–5.

    PubMed  Google Scholar 

  33. Jalili M, Azizkhani R. Lead toxicity resulting from chronic ingestion of opium. West J Emerg Med. 2009;10(4):244–6.

    PubMed  PubMed Central  Google Scholar 

  34. Kim JA, Lee SH, Choi SH, Jung KK, Park MS, Jeong JY, et al. Heavy metal risk management: case analysis. Toxicol Res. 2012;28(3):143–9.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Mehrpour O, Karrari P, Abdollahi M. Chronic lead poisoning in Iran; a silent disease. Daru. 2012;20(1):8.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Knapek J, Buchtova R. Vosmerova D. Determination of cadmium in poppy seeds and in poppy seeds containing products. Book of abstract. 4th international symposium on recent advances in food analysis. Prag 2009; 226–26.

  37. Lachman J, Hejtmankova A, Miholova D, et al. Relations among alkaloids, cadmium and zinc contents in opium poppy (Papaver somniferum L.). Plant Soil Environ. 2006;52(6):282–8.

    Article  CAS  Google Scholar 

  38. Joint FA, World Health Organization, WHO Expert Committee on Food Additives. Evaluation of certain Food Addit Contam: seventy-seventh report of the Joint FA. 2013: World Health Organization.

  39. Thompson CM, Kirman CR, Proctor DM, Haws LC, Suh M, Hays SM, et al. A chronic oral reference dose for hexavalent chromium-induced intestinal cancer. J Appl Toxicol. 2014;34(5):525–36.

    Article  CAS  PubMed  Google Scholar 

  40. Park RM, Bena JF, Stayner LT, Smith RJ, Gibb HJ, Lees PSJ. Hexavalent chromium and lung cancer in the chromate industry: a quantitative risk assessment. Risk Anal. 2004;24(5):1099–108.

    Article  Google Scholar 

  41. Proctor DM, Suh M, Campleman SL, Thompson CM. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures. Toxicology. 2014;325:160–79.

    Article  CAS  PubMed  Google Scholar 

  42. Naz A, Mishra BK, Gupta SK. Human health risk assessment of chromium in drinking water: a case study of Sukinda chromite mine, Odisha, India. Exposure and Health. 2016;8(2):253–64.

    Article  CAS  Google Scholar 

  43. Derbie A, Amdu A, Alamneh A, Tadege A, Solomon A, Elfu B, et al. Clinical profile of tetanus patients attended at Felege Hiwot referral hospital, Northwest Ethiopia: a retrospective cross sectional study. Springerplus. 2016;5(1):892.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Kaushik KS, Kapila K, Praharaj AK. Shooting up: the interface of microbial infections and drug abuse. J Med Microbiol. 2011;60(4):408–22.

    Article  PubMed  Google Scholar 

  45. Kimura AC, Higa JI, Levin RM, et al. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis. 2004;38(9):87–91.

    Article  Google Scholar 

  46. Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med. 2005;353(18):1945–54.

    Article  CAS  Google Scholar 

  47. Brazier JS, Morris TE, Duerden BI. Heat and acid tolerance of Clostridium novyi type a spores and their survival prior to preparation of heroin for injection. Anaerobe. 2003;9(3):141–4.

    Article  CAS  PubMed  Google Scholar 

  48. Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis. 2001;33(1):35–40.

    Article  CAS  PubMed  Google Scholar 

  49. Ascough S, Altmann DM. Anthrax in injecting drug users: the need for increased vigilance in the clinic. Expert Rev Anti-Infect Ther. 2015;13(6):681–4.

    Article  CAS  PubMed  Google Scholar 

  50. Booth MG, Hood J, Brooks TJ, et al. Anthrax infection in drug users. Lancet. 2010;375:1345–6.

    Article  PubMed  Google Scholar 

  51. Grunow R, Klee SR, Beyer W, et al. Anthrax among heroin users in Europe possibly caused by same Bacillus anthracis strain since 2000. Euro Surveill. 2013;18(13):1–9.

    Google Scholar 

  52. Davin-Regli A, Pages JM. Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment. Front Microbiol. 2015;6:1–10.

    Article  Google Scholar 

  53. Liu J, Zeng T, Su G, et al. The dissemination mode of drug-resistant genes in Enterobacter cloacae. Indian J Med Microbiol. 2015;33:87–92.

    Article  PubMed  Google Scholar 

  54. Shadnia S, Faiaz-Noori MR, Pajoumand A, Talaie H, Khoshkar A, Vosough-Ghanbari S, et al. A case report of opium body packer; review of the treatment protocols and mechanisms of poisoning. Toxicol Mech Methods. 2007;17(4):205–14.

    Article  CAS  PubMed  Google Scholar 

  55. Hassanian-Moghaddam H, Abolmasoumi Z. Consequence of body packing of illicit drugs. Arch Iran Med. 2007;10(1):20–3.

    PubMed  Google Scholar 

  56. Van Schaik W. The human gut resistome. Phil Trans R Soc B. 2015;370(1670):20140087. https://doi.org/10.1098/rstb.2014.0087.

    Article  CAS  PubMed  Google Scholar 

  57. Bottone EJ. Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev. 2010;23(2):382–98.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Pier G. Pseudomonas and related gram-negative bacillary infections. Goldman’s Cecil medicine. 2012.

    Chapter  Google Scholar 

  59. Dancer SJ, McNair D, Finn P, et al. Bacillus cereus cellulitis from contaminated heroin. J Med Microbiol. 2002;51(3):278–81.

    Article  CAS  PubMed  Google Scholar 

  60. Sousa C, Botelho C, Rodrigues D, Azeredo J, Oliveira R. Infective endocarditis in intravenous drug abusers: an update. Eur J Clin Microbiol Infect Dis. 2012;31(11):2905–10.

    Article  CAS  PubMed  Google Scholar 

  61. Peterson TC, Pearson C, Zekaj M, Hudson I, Fakhouri G, Vaidya R. Septic arthritis in intravenous drug abusers: a historical comparison of habits and pathogens. J Emerg Med. 2014;47(6):723–8.

    Article  PubMed  Google Scholar 

  62. Tuazon CU, Miller H, Shamsuddin D. Antimicrobial activity of street heroin. J Infect Dis. 1980;142(6):944.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by grant No. 19710127901001 of Islamic Azad University, Shahreza Branch, Shahreza, Iran.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amir Nili-Ahmadabadi.

Ethics declarations

Conflicts of interests

The authors declare that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aghababaei, R., Javadi, I., Nili-Ahmadabadi, A. et al. Occurrence of bacterial and toxic metals contamination in illegal opioid-like drugs in Iran: a significant health challenge in drug abusers. DARU J Pharm Sci 26, 77–83 (2018). https://doi.org/10.1007/s40199-018-0205-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40199-018-0205-5

Keywords

Navigation